MVSF-AB: accurate antibody–antigen binding affinity prediction via multi-view sequence feature learning
Bioinformatics · 2025
DOI: 10.1093/bioinformatics/btae579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, 2025. Verfasst von Minghui Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Software Engineering, Huazhong University of Science and Technology, Wuhan 430000, China. Hauptthemen laut MEDLINE: Machine Learning, Antigens, Antibodies, Antibody Affinity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation Project.
Abstract (Originalsprache)
Motivation Predicting the binding affinity between antigens and antibodies accurately is crucial for assessing therapeutic antibody effectiveness and enhancing antibody engineering and vaccine design. Traditional machine learning methods have been widely used for this purpose, relying on interfacial amino acids’ structural information. Nevertheless, due to technological limitations and high costs of acquiring structural data, the structures of most antigens and antibodies are unknown, and sequence-based methods have gained attention. Existing sequence-based approaches designed for protein-protein affinity prediction exhibit a significant drop in performance when applied directly to antibody–antigen affinity prediction due to imbalanced training data and lacking design in the model framework specifically for antibody–antigen, hindering the learning of key features of antibodies and antigens. Therefore, we propose MVSF-AB, a Multi-View Sequence Feature learning for accurate Antibody–antigen Binding affinity prediction. Results MVSF-AB designs a multi-view method that fuses semantic features and residue features to fully utilize the sequence information of antibody–antigen and predicts the binding affinity. Experimental results demonstrate that MVSF-AB outperforms existing approaches in predicting unobserved natural antibody–antigen affinity and maintains its effectiveness when faced with mutant strains of antibodies. Availability and implementation Datasets we used and source code are available on our public GitHub repository https://github.com/TAI-Medical-Lab/MVSF-AB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Software Engineering, Huazhong University of Science and Technology, Wuhan 430000, China.
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.
- School of Cyber Science and Engineering, Huazhong University of Science and Technology, Wuhan 430000, China.
- School of Information and Communication Technology, Griffith University, Queensland 4222, Australia.
- School of Data Science, City University of Hong Kong, Hong Kong 999077, China.
- Department of Computer Science and Engineering, Lehigh University, Bethlehem, PA 18018, United States.
ORCID-Profile: Shengshan Hu
Förderung
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation Project
Zitieren
APA
Li, M., Shi, Y., Hu, S., Hu, S., Guo, P., Wan, W., Zhang, L. Y., Pan, S., Li, J., Sun, L., & Lan, X. (2025). MVSF-AB: accurate antibody–antigen binding affinity prediction via multi-view sequence feature learning. Bioinformatics. https://doi.org/10.1093/bioinformatics/btae579
Vancouver
Li M, Shi Y, Hu S, Hu S, Guo P, Wan W, et al. MVSF-AB: accurate antibody–antigen binding affinity prediction via multi-view sequence feature learning. Bioinformatics. 2025. doi:10.1093/bioinformatics/btae579
BibTeX
@article{Li2025,
author = {Li, Minghui and Shi, Yao and Hu, Shengqing and Hu, Shengshan and Guo, Peijin and Wan, Wei and Zhang, Leo Yu and Pan, Shirui and Li, Jizhou and Sun, Lichao and Lan, Xiaoli},
title = {MVSF-AB: accurate antibody–antigen binding affinity prediction via multi-view sequence feature learning},
journal = {Bioinformatics},
year = {2025},
doi = {10.1093/bioinformatics/btae579}
}
EUVIMED